Senseye is at the forefront of neurotechnology with its proprietary Emotional Intelligence Engine (EIE), which analyses ocular data to provide insights into trauma-related conditions and potential applications for substance abuse.
Problem
- Diagnosis challenges: Traditional diagnostic methods are often slow and prone to errors, leading to delayed treatment and less effective outcomes.
- Lack of objective tools: The absence of objective tools for accurately monitoring and measuring mental health contributes to imprecise diagnoses and costly interventions.
- Subjective treatment: Treatment recommendations often lack a scientific basis, relying on subjective interpretations rather than data-driven insights.
Solution
- Mobile-based diagnostics: Senseye’s platform leverages mobile devices to measure nervous system activity through ocular data, providing digital diagnostics and severity assessments for mental health conditions.
- AI-powered insights: Senseye’s EIE analyses ocular data to deliver accurate diagnoses for conditions like PTSD, depression, and anxiety, with potential applications for substance abuse.
- Flexible commercialisation: Senseye plans to offer its technology through a flexible model, including SaaS, subscriptions, and per-test pricing, making it accessible for different needs.
Media Links
Type
Industrial & Manufacturing and Restaurant & Food Service
Focus Area
Deep Tech, Enterprise, and Sustainability
Capital Raised (US$)
21M to 50M
Operational HQ
United States
SECTOR
AI, Biometrics, and Computer Vision
status
Current
founders
David Zakariaie
partnered
2019
exited
You may be interested in...
